サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1561454

3D細胞培養市場レポート：製品、用途、エンドユーザー、地域別、2024年～2032年

3D Cell Culture Market Report by Product, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 136 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
3D細胞培養市場レポート：製品、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

3D細胞培養市場の世界市場規模は、2023年に23億2,320万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに74億1,870万米ドルに達し、2024-2032年の成長率（CAGR）は13.4％を示すと予測しています。がん診断のための3D組織工学モデルに対する需要の高まり、気道および気液界面オルガノイドに対するニーズの高まり、in vivoモデル系を必要とする研究における利用の増加が、市場を牽引する主な要因のいくつかを表しています。

3D細胞培養は、細胞が3次元的に増殖し、周囲の細胞外フレームワークと相互作用することを可能にする培養環境です。細胞をプレート上の平坦な単層で培養する従来の2D細胞培養とは対照的です。ハイドロゲルや不活性マトリックスなどの支持足場内で培養し、あらゆる方向への増殖を可能にします。細胞がクラスターやスフェロイドに自己組織化するためには、低接着性プレート、マイクロパターン表面、ハンギングドロップなど、足場を用いない方法に依存します。マイクロチップのチャンバー内で行われ、細胞全体に栄養分やその他の化学物質を運び、分配するための液体の流れを可能にします。二次元細胞培養に比べ、組織内の細胞が存在する実際の微小環境をより正確に表現しています。3D細胞培養は、その追加的な次元性によりin vivoでの細胞応答をより反映するため、3D細胞培養の需要は世界中で高まっています。

3D細胞培養市場傾向：

現在、in vivoモデル系を必要とする研究において、3D培養は臓器の典型的な形態や微細構造を忠実に模倣することができるため、3D細胞培養の利用が増加しており、市場の成長を支える重要な要因の一つとなっています。これに加えて、世界中の大衆の間で、がんやその他の臨床疾患を診断するための3D組織工学モデルの採用が増加しています。これは、体内組織や臓器に対する外来薬の影響を分析するための3D細胞培養の需要の増加とともに、有利な市場見通しを提供しています。加えて、3D細胞培養は2D技術と比べてシンプルで安価なin vitro腫瘍-宿主環境であるため、需要の高まりが市場の成長を後押ししています。さらに、呼吸器疾患に関する調査のために3Dモデルの利用が増加しており、業界の投資家に有利な成長機会を提供しています。これとは別に、抗ウイルス薬の開発と発見、実験的ウイルス学プラットフォーム、免疫反応の研究のために、気道と気液界面オルガノイドの需要が増加しています。このことは、新製品の発売や生物学研究における3Dプロトコルの幅広い応用と相まって、市場の成長を強化しています。

本レポートで扱う主な質問

  • 3D細胞培養市場の市場規模は？
  • 2024-2032年における3D細胞培養市場の世界市場成長率は？
  • 世界の3D細胞培養市場を牽引する主要因は何か？
  • 世界の3D細胞培養市場に対するCOVID-19の影響は？
  • 世界の3D細胞培養市場の製品別内訳は？
  • 世界の3D細胞培養市場の用途別内訳は？
  • 世界の3D細胞培養市場のエンドユーザー別内訳は？
  • 3D細胞培養市場の世界における主要地域は？
  • 世界の3D細胞培養市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の3D細胞培養市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • スキャフォルドベースのプラットフォーム
    • 市場動向
    • 市場予測
  • スキャフォルドフリーのプラットフォーム
    • 市場動向
    • 市場予測
  • マイクロチップ
    • 市場動向
    • 市場予測
  • バイオリアクター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • がん研究
    • 市場動向
    • 市場予測
  • 幹細胞研究
    • 市場動向
    • 市場予測
  • 創薬
    • 市場動向
    • 市場予測
  • 再生医療
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • バイオテクノロジーおよび製薬企業
    • 市場動向
    • 市場予測
  • 受託研究機関
    • 市場動向
    • 市場予測
  • 学術機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3D Biotek LLC
    • Advanced Biomatrix Inc.
    • Avantor Inc.
    • CN Bio Innovations Limited
    • Corning Incorporated
    • Emulate Inc.
    • InSphero AG
    • Lonza Group AG
    • Merck KGaA
    • Promocell GmbH
    • Synthecon Inc
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: 3D Cell Culture Market: Major Drivers and Challenges
  • Figure 2: Global: 3D Cell Culture Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: 3D Cell Culture Market: Breakup by Product (in %), 2023
  • Figure 5: Global: 3D Cell Culture Market: Breakup by Application (in %), 2023
  • Figure 6: Global: 3D Cell Culture Market: Breakup by End User (in %), 2023
  • Figure 7: Global: 3D Cell Culture Market: Breakup by Region (in %), 2023
  • Figure 8: Global: 3D Cell Culture (Scaffold-Based Platforms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: 3D Cell Culture (Scaffold-Based Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: 3D Cell Culture (Scaffold-Free Platforms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: 3D Cell Culture (Scaffold-Free Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: 3D Cell Culture (Microchips) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: 3D Cell Culture (Microchips) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: 3D Cell Culture (Bioreactors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: 3D Cell Culture (Bioreactors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: 3D Cell Culture (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: 3D Cell Culture (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: 3D Cell Culture (Cancer Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: 3D Cell Culture (Cancer Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: 3D Cell Culture (Stem Cell Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: 3D Cell Culture (Stem Cell Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: 3D Cell Culture (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: 3D Cell Culture (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: 3D Cell Culture (Regenerative Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: 3D Cell Culture (Regenerative Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: 3D Cell Culture (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: 3D Cell Culture (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: 3D Cell Culture (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: 3D Cell Culture (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: 3D Cell Culture (Contract Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: 3D Cell Culture (Contract Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: 3D Cell Culture (Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: 3D Cell Culture (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: 3D Cell Culture (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: 3D Cell Culture (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: 3D Cell Culture Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: 3D Cell Culture Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: 3D Cell Culture Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: 3D Cell Culture Industry: SWOT Analysis
  • Figure 86: Global: 3D Cell Culture Industry: Value Chain Analysis
  • Figure 87: Global: 3D Cell Culture Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: 3D Cell Culture Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: 3D Cell Culture Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: 3D Cell Culture Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: 3D Cell Culture Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: 3D Cell Culture Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: 3D Cell Culture Market: Competitive Structure
  • Table 7: Global: 3D Cell Culture Market: Key Players
目次
Product Code: SR112024A4527

The global 3D cell culture market size reached US$ 2,323.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 7,418.7 Million by 2032, exhibiting a growth rate (CAGR) of 13.4% during 2024-2032. The growing demand for 3D tissue-engineered models to diagnose cancer, rising need for airway and air-liquid interface organoids, and increasing utilization in studies that require in vivo model systems represent some of the key factors driving the market.

3D cell culture is a culture environment that enables cells to grow and interact with surrounding extracellular frameworks in three dimensions. It is a contrast to traditional 2D cell cultures wherein cells are grown in a flat monolayer on a plate. It can be cultured within supporting scaffolds, such as hydrogels and inert matrices, to allow growth in all directions. It relies on scaffold-free methods, such as low-adhesion plates, micropatterned surfaces, and hanging drops, for allowing cells to self-assemble into clusters or spheroids. It is performed within the chambers of a microchip that allows the flow of liquid to transport and distribute nutrients or other chemicals throughout the cells. It represents more accurately the actual microenvironment wherein cells reside in tissues compared to 2D cell culture. As it is more reflective of in vivo cellular responses due to the additional dimensionality of 3D cultures, the demand for 3D cell culture is rising across the globe.

3D Cell Culture Market Trends:

At present, the increasing utilization of 3D cell culture in studies that require in vivo model systems, as 3D cultures can closely mimic a typical morphology and microarchitecture of organs, represents one of the key factors supporting the growth of the market. Besides this, there is a rise in the employment of 3D tissue-engineered models to diagnose cancer and other clinical disorders among the masses around the world. This, along with the growing demand for 3D cell culture to analyze the effects of a foreign drug over body tissues and organs, is offering a favorable market outlook. In addition, the rising demand for 3D cell culture, as it is a simple and inexpensive in vitro tumor-host environment compared to 2D techniques, is propelling the growth of the market. Moreover, the increasing usage of 3D models for performing research about respiratory diseases is offering lucrative growth opportunities to industry investors. Apart from this, there is an increase in the demand for airway and air-liquid interface organoids to develop and discover antiviral drugs and as experimental virology platforms and study the immune responses. This, coupled with the launch of new products and wide applications of 3D protocols in biological research, is strengthening the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D cell culture market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.

Product Insights:

  • Scaffold-Based Platforms
  • Scaffold-Free Platforms
  • Microchips
  • Bioreactors
  • Others

The report has provided a detailed breakup and analysis of the 3D cell culture market based on the product. This includes scaffold-based platforms, scaffold-free platforms, microchips, bioreactors, and others. According to the report, scaffold-based platforms represented the largest segment.

Application Insights:

  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Regenerative Medicine
  • Others

A detailed breakup and analysis of the 3D cell culture market based on the application has also been provided in the report. This includes cancer research, stem cell research, drug discovery, regenerative medicine, and others. According to the report, cancer research accounted for the largest market share.

End User Insights:

  • Biotechnology and Pharmaceutical Companies
  • Contract Research Laboratories
  • Academic Institutes
  • Others

A detailed breakup and analysis of the 3D cell culture market based on the end user has also been provided in the report. This includes biotechnology and pharmaceutical companies, contract research laboratories, academic institutes, and others. According to the report, biotechnology and pharmaceutical companies accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D cell culture. Some of the factors driving the North America 3D cell culture market included the government funding for the development of advanced 3D cell culture models, high healthcare spending, the presence of a large number of universities and research organizations, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global 3D cell culture market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include 3D Biotek LLC, Advanced Biomatrix Inc., Avantor Inc., CN Bio Innovations Limited, Corning Incorporated, Emulate Inc., InSphero AG, Lonza Group AG, Merck KGaA, Promocell GmbH, Synthecon Inc, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the 3D cell culture market?
  • 2. What is the expected growth rate of the global 3D cell culture market during 2024-2032?
  • 3. What are the key factors driving the global 3D cell culture market?
  • 4. What has been the impact of COVID-19 on the global 3D cell culture market?
  • 5. What is the breakup of the global 3D cell culture market based on the product?
  • 6. What is the breakup of the global 3D cell culture market based on the application?
  • 7. What is the breakup of the global 3D cell culture market based on the end user?
  • 8. What are the key regions in the global 3D cell culture market?
  • 9. Who are the key players/companies in the global 3D cell culture market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global 3D Cell Culture Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Scaffold-Based Platforms
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Scaffold-Free Platforms
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Microchips
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Bioreactors
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Cancer Research
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Stem Cell Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Regenerative Medicine
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Biotechnology and Pharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Contract Research Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3D Biotek LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Advanced Biomatrix Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Avantor Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 CN Bio Innovations Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Corning Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Emulate Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 InSphero AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Lonza Group AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Merck KGaA
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Promocell GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Synthecon Inc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis